APA (7th ed.) Citation

S, M., & W, L. (2026). In adults with acute VTE, apixaban vs. rivaroxaban reduced clinically relevant bleeding at 3 mo. Annals of internal medicine, 179(6), JC64. https://doi.org/10.7326/ANNALS-26-01793-JC

Chicago Style (17th ed.) Citation

S, Mithoowani, and Lim W. "In Adults with Acute VTE, Apixaban Vs. Rivaroxaban Reduced Clinically Relevant Bleeding at 3 Mo." Annals of Internal Medicine 179, no. 6 (2026): JC64. https://doi.org/10.7326/ANNALS-26-01793-JC.

MLA (9th ed.) Citation

S, Mithoowani, and Lim W. "In Adults with Acute VTE, Apixaban Vs. Rivaroxaban Reduced Clinically Relevant Bleeding at 3 Mo." Annals of Internal Medicine, vol. 179, no. 6, 2026, p. JC64, https://doi.org/10.7326/ANNALS-26-01793-JC.